FLUCELVAX INFLUENZA VIRUS VACCINE

Serial Number 85720254
Registration 4515496
710

Registration Progress

Application Filed
Sep 4, 2012
Under Examination
Feb 5, 2013
Approved for Publication
Nov 21, 2012
Published for Opposition
Dec 11, 2012
Registered
Apr 15, 2014

Trademark Image

FLUCELVAX INFLUENZA VIRUS VACCINE

Basic Information

Serial Number
85720254
Registration Number
4515496
Filing Date
September 4, 2012
Registration Date
April 15, 2014
Published for Opposition
December 11, 2012
Cancellation Date
November 20, 2020
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Nov 20, 2020

Rights Holder

SEQIRUS UK LIMITED

99
Address
POINT, 29 MARKET STREET
MAIDENHEAD, BERKSHIRE SL6 8AA
GB

Ownership History

Novartis AG

Original Applicant
03
Basel CH

Novartis AG

Owner at Publication
03
Basel CH

Novartis AG

Original Registrant
03
Basel CH

SEQIRUS UK LIMITED

New Owner After Registration #1
99
MAIDENHEAD, BERKSHIRE GB

Legal Representation

Attorney
Nancy Sabarra

USPTO Deadlines

Next Deadline
3080 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2014-04-15)
Due Date
April 15, 2034
Grace Period Ends
October 15, 2034

Application History

27 events
Date Code Type Description Documents
Nov 20, 2020 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Apr 15, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 5, 2017 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Jan 31, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 29, 2016 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 29, 2016 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 28, 2016 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Apr 15, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 8, 2014 SUNA O NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED Loading...
Mar 4, 2014 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 25, 2014 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 17, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 22, 2014 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 22, 2014 IUAF S USE AMENDMENT FILED Loading...
Aug 1, 2013 EXRA O NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED Loading...
Jul 30, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 30, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 30, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 5, 2013 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2012 NPUB O NOTICE OF PUBLICATION Loading...
Oct 13, 2012 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Sep 25, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 18, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2012 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Sep 11, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 7, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the term "FLUCELVAX" under the words "INFLUENZA VACCINE." Around the letter "X" in "FLUCELVAX" is a semi-circular starburst design composed of dots of varying sizes.
Color Claim
Color is not claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INFLUENZA VACCINE"